Search clinical trials for: Childhood Cancer Survivors

Total 89773 results

National Cancer Institute (NCI)

Completed

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

Gastrointestinal Neoplasms | Pancreatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Biological Specimen Collection for Laboratory Methods Development and Training Purposes

Healthy

United States
National Cancer Institute (NCI)

Completed

Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

HIV Infection

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

Neoplasm

United States
National Cancer Institute (NCI)

Completed

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

Neoplasm Metastasis | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy

Glioma | Sarcoma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Lymphoma | Myelodysplastic Syndromes | Myeloid Leukemia | Hematologic Neoplasms | Graft vs Host Disease

United States
National Cancer Institute (NCI)

Completed

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Mycoses | Candidiasis | Fungemia | Aspergillosis

United States
National Cancer Institute (NCI)

Completed

Combination Drug Treatment of Pediatric HIV Infection

HIV Infection

United States
National Cancer Institute (NCI)

Completed

Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer

Neoplasm

United States
National Cancer Institute (NCI)

Completed

Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR

Leukoplakia | Periodontal Disease

United States
National Cancer Institute (NCI)

Completed

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

Melanoma | Sarcoma

United States
National Institute on Deafness and Other Communication...

Completed

The Effects of Upper Airway and Digestive Tract Tumors on the Immune System

Papilloma | Esophageal Neoplasm | Squamous Cell Carcinoma | Head and Neck Neoplasm | Laryngeal Neoplasm

United States
National Cancer Institute (NCI)

Completed

Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis

Fibrosis | Radiation Injuries

United States
National Cancer Institute (NCI)

Completed

Voriconazole to Treat Fungal Infections

Mycoses

United States
National Cancer Institute (NCI)

Completed

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Psoriasis | Basal Cell Carcinoma | Keratosis Palmaris et Plantaris

United States
National Cancer Institute (NCI)

Completed

Micellar Paclitaxel to Treat Severe Psoriasis

Psoriasis

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Melanoma | Lymphoma | Renal Cell Carcinoma | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Sepsis | Hematologic Diseases | Breast Neoplasms | Neutropenia | Fever

United States
National Cancer Institute (NCI)

Completed

A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2

Gastrointestinal Diseases | Candidiasis, Oral | Stomatitis

United States
National Cancer Institute (NCI)

Completed

Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial

Neoplasm Metastasis | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

Familial Prostate Cancer

Prostatic Neoplasms | Neoplastic Syndromes, Hereditary

United States
National Cancer Institute (NCI)

Completed

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

Breast Neoplasm | Hereditary Neoplastic Syndrome

United States
National Cancer Institute (NCI)

Completed

Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials

Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer

Colorectal Neoplasms

United States
National Cancer Institute (NCI)

Completed

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

HIV Infections | Healthy

United States
National Cancer Institute (NCI)

Completed

Physicians Survey on Genetic Testing

Cancer
National Cancer Institute (NCI)

Completed

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

Burkitt Lymphoma | Lymphoma, Large-Cell, Diffuse | Lymphoma, Small Noncleaved-Cell

United States
National Cancer Institute (NCI)

Completed

Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children

Depressive Disorder | HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients

Ovarian Neoplasms

United States
National Cancer Institute (NCI)

Completed

Determination of HIV-1 Production by the Prostate

HIV Infections

United States
National Cancer Institute (NCI)

Completed

Study of Etoposide in Breast Cancer Patients

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

Prostatic Neoplasms

United States
National Institutes of Health Clinical Center (CC)

Completed

Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics

Neoplasms | Constipation

United States
National Cancer Institute (NCI)

Completed

Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study

Osteosarcoma

United States
National Cancer Institute (NCI)

Completed

A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma

Prostatic Neoplasm

United States
National Institutes of Health Clinical Center (CC)

Completed

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

Myelodysplastic Syndromes | Hematologic Diseases

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Topical Antiflammin-2 for Psoriasis

Psoriasis

United States
National Cancer Institute (NCI)

Completed

The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors

Sarcoma | Neoplasms

United States
National Cancer Institute (NCI)

Completed

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia

Mycoses | Neutropenia | Fever

United States
National Institute of Mental Health (NIMH)

Completed

Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)

Obsessive Compulsive Disorder | Tic Disorder | Streptococcal Infection | Mental Disorder Diagnosed in Childhood

United States
National Cancer Institute (NCI)

Completed

In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

Lymphoma | Leukemia | Neoplasm | Immunologic Deficiency Syndrome

United States
National Cancer Institute (NCI)

Completed

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

Acquired Immunodeficiency Syndrome | HIV Infection

United States
National Cancer Institute (NCI)

Completed

Analysis of NF2 Mutations in Radiation-Related Neural Tumors

Neural Tumors

United States
National Cancer Institute (NCI)

Completed

Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors

Brain Tumor

United States
National Cancer Institute (NCI)

Completed

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Phase I Study of Intrathecal Topotecan

Lymphoma | Leukemia | Meningeal Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

Breast Cancer | Breast Neoplasms

United States

3

Subscribe